Literature DB >> 14615645

Preventing diabetic retinopathy through control of systemic factors.

Atul Jain1, David Sarraf, Donald Fong.   

Abstract

PURPOSE OF REVIEW: Diabetic retinopathy (DR), the leading cause of vision loss in working-age adults, is associated with many systemic factors that contribute to the severity and progression of this disease. Intensive glycemic and blood pressure control has been shown to delay both the onset and progression of diabetic retinopathy. RECENT
FINDINGS: Studies involving angiotensin-converting enzyme inhibitors are currently underway to elucidate the efficacy of these drugs in further reducing the progression of diabetic retinopathy by means other than just hypertensive control. Dyslipidemia is associated with macular exudates and vision loss. Anticoagulation with aspirin is neither contraindicated in diabetics nor associated with prevention or progression of diabetic retinopathy. The effects of smoking on diabetic retinopathy are equivocal. Pregnancy may be associated with the progression of diabetic retinopathy in the absence of long-term effects if serum glucose levels are well monitored and controlled prior to and during pregnancy.
SUMMARY: Genetic research is providing more insight into the pathogenesis and mechanisms of diabetic retinopathy, allowing possible identification of those at higher risk for developing diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615645     DOI: 10.1097/00055735-200312000-00012

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  7 in total

1.  Epidemic studies of diabetic retinopathy in China-a review.

Authors:  Lei Liu; Li-Min Liu; Yue-Dong Hu; Kang Chen; Hao Feng; Yi-Zhou Sun; Lei Chen
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

2.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

3.  Incidence Density and Risk Factors of Diabetic Retinopathy Within Type 2 Diabetes: A Five-Year Cohort Study in China (Report 1).

Authors:  Lei Liu; Jingyang Wu; Song Yue; Jin Geng; Jie Lian; Weiping Teng; Desheng Huang; Lei Chen
Journal:  Int J Environ Res Public Health       Date:  2015-07-10       Impact factor: 3.390

4.  Hospital Prevalence of Retinopathy in Patients with Newly-Diagnosed Type 2 Diabetes.

Authors:  Waseem M Al-Zamil
Journal:  Saudi J Med Med Sci       Date:  2016-11-16

5.  Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways.

Authors:  J Matthew Diffley; Mingyuan Wu; Mimi Sohn; Weiwei Song; Samar M Hammad; Timothy J Lyons
Journal:  Mol Vis       Date:  2009-01-19       Impact factor: 2.367

Review 6.  The evolving treatment options for diabetic macular edema.

Authors:  Atul Jain; Neeta Varshney; Colin Smith
Journal:  Int J Inflam       Date:  2013-09-09

7.  A needs assessment of people living with diabetes and diabetic retinopathy.

Authors:  Claudette E Hall; Anthony B Hall; Gerjo Kok; Joyse Mallya; Paul Courtright
Journal:  BMC Res Notes       Date:  2016-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.